VEGFA and peripheral arterial disease: The alternative splicing of exon 8 of VEGF-A has been reported in human and experimental peripheral arterial disease (PAD) where muscle ischaemia induces an angiogenic response that is frequently inadequate to meet the tissue perfusion needs [8].